Progyny (NASDAQ: PGNY) reported Q4 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $214.3 million versus the consensus estimate of $211.78 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.